THOMPSON JOHN CRAIG 4/A
4/A · Anthera Pharmaceuticals Inc · Filed Sep 7, 2017
Insider Transaction Report
Form 4/AAmended
THOMPSON JOHN CRAIG
DirectorPresident & CEO
Transactions
- Purchase
Common stock
2017-09-07$1.43/sh+10,400$14,893→ 11,298 total
Footnotes (1)
- [F1]The Reporting Person acquired the shares in the open market at an average cost of $1.432. Shares have been adjusted to reflect the issuer's 1-for-8 reverse stock split effectuated on April 28, 2017. This is an amendment to correct two errors in the original form 4 filed on September 7, 2017.